Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating) – Investment analysts at Zacks Small Cap dropped their FY2022 EPS estimates for Lexaria Bioscience in a research note issued to investors on Wednesday, August 3rd. Zacks Small Cap analyst J. Vandermosten now expects that the company will post earnings per share of ($1.21) for the year, down from their previous estimate of ($1.09). The consensus estimate for Lexaria Bioscience’s current full-year earnings is ($1.09) per share.
Lexaria Bioscience Price Performance
NASDAQ LEXX opened at $2.83 on Friday. The firm has a 50 day simple moving average of $2.64 and a 200-day simple moving average of $3.06. Lexaria Bioscience has a one year low of $1.85 and a one year high of $7.20.
Institutional Inflows and Outflows
About Lexaria Bioscience
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others.
- Get a free copy of the StockNews.com research report on Lexaria Bioscience (LEXX)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.